BARD Diagnostic Sciences, Inc.
3Patents
0Active
3Granted
22Portfolio score
Filing activity: Jun 2, 1995 → Mar 5, 1998
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6017703A | Methods and compositions for screening for or modulating a tumor associated antigen | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6221621A | Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5541076A | Methods for determining the invasiveness of a bladder tumor | Emerging Cross-Sectional Technologies | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.